Archive for Март 30th, 2008
Zimulti Acomplia Report Covers FDA Panel Meeting on Diet Pill Rimonabant
The make-or-break FDA advisory panel meeting on diet drug rimonabant ( Acomplia (rimonabant) ) will be the subject of team coverage on June 13th by staff of the Zimulti Acomplia , leading independent source of news about rimonabant.
The day-long meeting, which will air concerns raised [...]
New Patients Sought for Study of Acomplia Role in Curbing Alcohol Consumption
The National Institute on Alcohol Abuse and Alcoholism ( Acomplia (rimonabant) ) is continuing to seeking volunteers for a Phase II clinical trial exploring the potential of the promising obesity drug Acomplia (rimonabant) in curbing alcohol consumption.
A spokesperson for NIAAA said the trial [...]
